Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy is a strong and well-established company with a solid financial track record. Revenue and EBITDA both exceeded projections and while profitability may have been slightly lower than expected, it is still within the company's guidance. With a diversified payment source and continued growth in their Physical therapy operations and Industrial injury prevention services, US Physical Therapy is well-positioned for future success.

Bears say

US Physical Therapy is a company with a diverse revenue stream, but its reliance on managed care programs, commercial health insurance, and Medicare/Medicaid makes it vulnerable to any changes in these payment sources. Despite potential growth through hospital partnerships and a positive 2026 outlook, the company has already experienced Medicaid rate pressure in Q1 and may continue to face pricing headwinds for its Medicare business. Additionally, potential growth opportunities through partnerships may take time to fully contribute to revenue.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.